Abstract CN75
Background
The Utrecht Symptom Diary (USD) is a Dutch validated patient-reported outcome measurement tool (PROM) - based on the Edmonton Symptom Assessment System - to assess and monitor symptoms in cancer patients. This study aimed to evaluate the added items on the treatment specific outpatient USD in cancer patients receiving intravenous chemotherapy and/or targeted therapy.
Methods
Observational longitudinal retrospective cohort study including all adult outpatients with cancer receiving intravenous chemotherapy and/or targeted therapy in an academic hospital in the Netherlands who completed at least one outpatient USD as part of routine care (2012-2021). Content, criterion and construct validation were assessed.
Results
1733 patients who completed ≥1outpatient USD during intravenous chemotherapy and/or targeted therapy were included for analysis. Content validity (relevance, comprehensiveness) was shown. Criterion validation was confirmed for all added items of the outpatient USD – except for the item on oral pain. Additional analysis showed that mouth problems were detected with both outpatient USD items oral pain and dry mouth. Construct validity was confirmed for the items hair changes and skin and nail problems. Construct validity on eye problems was not tested due to the low number of paired outpatient USDs.
Conclusions
The outpatient USD is a valid PROM in outpatients with cancer receiving intravenous chemotherapy and/or targeted therapy. Since its validity in this broad group of patients we think the outpatient USD is widely applicable. Additionally, to providing tailored supportive symptom care, the USD-data can be used to increase knowledge about symptom burden in daily practice in this population.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The author.
Funding
Has not received any funding.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
CN64 - Assessment of depression among lung cancer patients with type 2 diabetes using centre for epidemiologic studies depression scale (CES-D)
Presenter: Maria Lavdaniti
Session: Poster session 25
Resources:
Abstract
CN65 - Assessment of fatigue in elderly hospitalized cancer patients undergoing chemotherapy: A pilot study
Presenter: Maria Lavdaniti
Session: Poster session 25
Resources:
Abstract
CN66 - Cancer symptom clusters, nutritional status and quality of life of patients with cancer undergoing outpatient chemotherapy
Presenter: Luis Carlos Lopes-Júnior
Session: Poster session 25
Resources:
Abstract
CN67 - Comparison of existing guidelines for healthcare professionals on the perceived symptoms of breast cancer patients with registered symptoms in the medical records: Preliminary results
Presenter: Trine Lund-Jacobsen
Session: Poster session 25
Resources:
Abstract
CN68 - Experiences and needs of rectal cancer survivors without or with minor low anterior resection syndrome
Presenter: Fien Serroyen
Session: Poster session 25
Resources:
Abstract
CN69 - Experiences of patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A qualitative study
Presenter: Jill Dobbelaer
Session: Poster session 25
Resources:
Abstract
CN70 - Out of hours symptom triage and supportive care
Presenter: Kate Mckendry
Session: Poster session 25
Resources:
Abstract
CN71 - SensiEx: A randomized pilot trial Sensorimotor training using whole body vibration exercise to reduce chemotherapy-induced peripheral neuropathy after treatment for breast cancer
Presenter: Malin Backman
Session: Poster session 25
Resources:
Abstract
CN72 - Symptom burden, quality of life and emotional status of patients with advanced lung cancer seen at the functional lung unit
Presenter: Isabel Brao Perez
Session: Poster session 25
Resources:
Abstract
CN73 - Symptom management in patients with chemotherapy-induced hand-foot syndrome: A qualitative study
Presenter: jie Zhang
Session: Poster session 25
Resources:
Abstract